Doximity, Inc. (DOCS) is a publicly traded Healthcare sector company. As of May 21, 2026, DOCS trades at $19.65 with a market cap of $3.62B and a P/E ratio of 15.59. DOCS moved +3.30% today. Year to date, DOCS is -56.53%; over the trailing twelve months it is -62.53%. Its 52-week range spans $17.15 to $85.21. Analyst consensus is buy with an average price target of $26.78. Rallies surfaces DOCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded DOCS stock?
Recent politician trading activity in DOCS includes disclosures from Jonathan Jackson and Jonathan Jackson. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
DOCS Key Metrics
Key financial metrics for DOCS
Metric
Value
Price
$19.65
Market Cap
$3.62B
P/E Ratio
15.59
EPS
$1.27
Dividend Yield
0.00%
52-Week High
$85.21
52-Week Low
$17.15
Volume
3.63M
Avg Volume
0
Revenue (TTM)
$637.78M
Net Income
$239.40M
Gross Margin
89.75%
Congressional Trades in DOCS
Jonathan Jackson sale DOCS on Nov 6, 2025 (amount: $50.00K) for Joint.
Jonathan Jackson purchase DOCS on Aug 25, 2025 (amount: $50.00K) for Joint.
Recent politician trading activity in DOCS includes disclosures from Jonathan Jackson and Jonathan Jackson. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in DOCS?
Yes. Rallies tracks politician and congressional stock disclosures for DOCS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is DOCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DOCS. It does not provide personalized investment advice.
